These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Heart rate variability assessment early after acute myocardial infarction. Pathophysiological and prognostic correlates. GUSTO ECG Substudy Investigators. Global Utilization of Streptokinase and TPA for Occluded Arteries. Singh N, Mironov D, Armstrong PW, Ross AM, Langer A. Circulation; 1996 Apr 01; 93(7):1388-95. PubMed ID: 8641028 [Abstract] [Full Text] [Related]
3. Thrombolysis and Q wave versus non-Q wave first acute myocardial infarction: a GUSTO-I substudy. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries Investigators. Barbagelata A, Califf RM, Sgarbossa EB, Goodman SG, Stebbins AL, Granger CB, Suarez LD, Borruel M, Gates K, Starr S, Wagner GS. J Am Coll Cardiol; 1997 Mar 15; 29(4):770-7. PubMed ID: 9091523 [Abstract] [Full Text] [Related]
4. Increased left ventricular dysfunction in elderly patients despite successful thrombolysis: the GUSTO-I angiographic experience. Lesnefsky EJ, Lundergan CF, Hodgson JM, Nair R, Reiner JS, Greenhouse SW, Califf RM, Ross AM. J Am Coll Cardiol; 1996 Aug 15; 28(2):331-7. PubMed ID: 8800106 [Abstract] [Full Text] [Related]
6. Differential effects of tissue plasminogen activator and streptokinase on infarct size and on rate of enzyme release: influence of early infarct related artery patency. The GUSTO Enzyme Substudy. Baardman T, Hermens WT, Lenderink T, Molhoek GP, Grollier G, Pfisterer M, Simoons ML. Eur Heart J; 1996 Feb 15; 17(2):237-46. PubMed ID: 8732377 [Abstract] [Full Text] [Related]
10. Noninvasive assessment of speed and stability of infarct-related artery reperfusion: results of the GUSTO ST segment monitoring study. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. Langer A, Krucoff MW, Klootwijk P, Veldkamp R, Simoons ML, Granger C, Califf RM, Armstrong PW. J Am Coll Cardiol; 1995 Jun 15; 25(7):1552-7. PubMed ID: 7759706 [Abstract] [Full Text] [Related]
15. Long-term prognostic importance of patency of the infarct-related coronary artery after thrombolytic therapy for acute myocardial infarction. White HD, Cross DB, Elliott JM, Norris RM, Yee TW. Circulation; 1994 Jan 15; 89(1):61-7. PubMed ID: 8281696 [Abstract] [Full Text] [Related]
16. Coronary revascularization surgery after myocardial infarction: impact of bypass surgery on survival after thrombolysis. GUSTO Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. Tardiff BE, Califf RM, Morris D, Bates E, Woodlief LH, Lee KL, Green C, Rutsch W, Betriu A, Aylward PE, Topol EJ. J Am Coll Cardiol; 1997 Feb 15; 29(2):240-9. PubMed ID: 9014973 [Abstract] [Full Text] [Related]
17. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. GUSTO Angiographic Investigators. N Engl J Med; 1993 Nov 25; 329(22):1615-22. PubMed ID: 8232430 [Abstract] [Full Text] [Related]
18. Early and 1-year clinical outcome of patients' evolving non-Q-wave versus Q-wave myocardial infarction after thrombolysis. Results from The TIMI II Study. Aguirre FV, Younis LT, Chaitman BR, Ross AM, McMahon RP, Kern MJ, Berger PB, Sopko G, Rogers WJ, Shaw L. Circulation; 1995 May 15; 91(10):2541-8. PubMed ID: 7743615 [Abstract] [Full Text] [Related]